{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:37:15Z","timestamp":1793039835011,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.biopha.2018.07.060","type":"journal-article","created":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T16:35:30Z","timestamp":1531586130000},"page":"1024-1030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Rho kinase, a potential target in the treatment of metabolic syndrome"],"prefix":"10.1016","volume":"106","author":[{"given":"Vajiheh","family":"Jahani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Kavousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soghra","family":"Mehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.07.060_bib0005","doi-asserted-by":"crossref","unstructured":"Alberti, K.G.M.M., P. Zimmet, and J. Shaw, The metabolic syndrome\u2014a new worldwide definition. The Lancet. 366(9491): p. 1059-1062.","DOI":"10.1016\/S0140-6736(05)67402-8"},{"key":"10.1016\/j.biopha.2018.07.060_bib0010","doi-asserted-by":"crossref","first-page":"e110446","DOI":"10.1371\/journal.pone.0110446","article-title":"Rho-kinase inhibition ameliorates metabolic disorders through activation of AMPK pathway in mice","author":"Noda","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.07.060_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/jsfa.9115","article-title":"Effects of silymarin on the metabolic syndrome; a review","author":"Vahabzadeh","year":"2018","journal-title":"J. Sci. Food Agric."},{"issue":"12","key":"10.1016\/j.biopha.2018.07.060_bib0020","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.24723","article-title":"Prevalence of metabolic syndrome and its components in the iranian adult population: a systematic review and meta-analysis","volume":"17","author":"Amirkalali","year":"2015","journal-title":"Iran. Red Crescent Med. J."},{"key":"10.1016\/j.biopha.2018.07.060_bib0025","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00210-016-1256-0","article-title":"Rosemary (Rosmarinus officinalis) as a potential therapeutic plant in metabolic syndrome: a review","author":"Hassani","year":"2016","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2018.07.060_bib0030","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ptr.5805","article-title":"Effects of avocado (Persea americana) on metabolic syndrome: a comprehensive systematic review","volume":"31","author":"Tabeshpour","year":"2017","journal-title":"Phytother. Res."},{"issue":"6916","key":"10.1016\/j.biopha.2018.07.060_bib0035","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature01148","article-title":"Rho GTPases in cell biology","volume":"420","author":"Etienne-Manneville","year":"2002","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.biopha.2018.07.060_bib0040","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jacc.2006.12.043","article-title":"Increased Rho kinase activity in a taiwanese population with metabolic syndrome","volume":"49","author":"Liu","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"24","key":"10.1016\/j.biopha.2018.07.060_bib0045","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1128\/MCB.22.24.8467-8477.2002","article-title":"Rho GTPase\/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B\/Akt in human endothelial cells","volume":"22","author":"Ming","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.060_bib0050","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/HYPERTENSIONAHA.113.02296","article-title":"Rho-associated kinase activity is a predictor of cardiovascular outcomes","volume":"63","author":"Kajikawa","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2018.07.060_bib0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.cellbio.21.020604.150721","article-title":"Rho GTPases: biochemistry and biology","volume":"21","author":"Jaffe","year":"2005","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2018.07.060_bib0060","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jacc.2006.06.082","article-title":"Roles of Rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffness","volume":"49","author":"Noma","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2018.07.060_bib0065","doi-asserted-by":"crossref","DOI":"10.4161\/sgtp.29846","article-title":"Rho-associated coiled-coil containing kinases (ROCK): structure, regulation, and functions","volume":"5","author":"Julian","year":"2014","journal-title":"Small GTPases"},{"issue":"1","key":"10.1016\/j.biopha.2018.07.060_bib0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/excr.2000.5046","article-title":"Regulation and functions of Rho-associated kinase","volume":"261","author":"Amano","year":"2000","journal-title":"Exp. Cell. Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.060_bib0075","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1074\/jbc.M508847200","article-title":"The structure of dimeric ROCK I reveals the mechanism for ligand selectivity","volume":"281","author":"Jacobs","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.060_bib0080","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.trsl.2014.05.001","article-title":"Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities","volume":"164","author":"Cavalera","year":"2014","journal-title":"Transl. Res."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.060_bib0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3904\/kjim.2010.25.2.119","article-title":"Molecular mechanism of insulin resistance in obesity and type 2 diabetes","volume":"25","author":"Choi","year":"2010","journal-title":"Korean J. Intern. Med."},{"issue":"9","key":"10.1016\/j.biopha.2018.07.060_bib0090","first-page":"1680","article-title":"Association of Rho\/Rho-kinase gene polymorphisms and expressions with obesity-related metabolic syndrome","volume":"19","author":"Tabur","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.060_bib0095","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cmet.2005.06.011","article-title":"Role of Rho-kinase in regulation of insulin action and glucose homeostasis","volume":"2","author":"Furukawa","year":"2005","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.060_bib0100","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1210\/me.2004-0413","article-title":"Akt activation is required at a late stage of insulin-induced GLUT4 translocation to the plasma membrane","volume":"19","author":"van Dam","year":"2005","journal-title":"Mol. Endocrinol."},{"issue":"5","key":"10.1016\/j.biopha.2018.07.060_bib0105","doi-asserted-by":"crossref","first-page":"H1597","DOI":"10.1152\/ajpheart.00026.2004","article-title":"Insulin resistance and hypertension","volume":"286","author":"Sowers","year":"2004","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.060_bib0110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.febslet.2009.11.082","article-title":"Advanced glycation end products increase endothelial permeability through the RAGE\/Rho signaling pathway","volume":"584","author":"Hirose","year":"2010","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.060_bib0115","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/bcp.12196","article-title":"Rho kinase inhibition in diabetic kidney disease","volume":"76","author":"Komers","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2018.07.060_bib0120","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1097\/01.ASN.0000067412.18899.9B","article-title":"Oxidized LDL and its compound lysophosphatidylcholine potentiate AngII-induced vasoconstriction by stimulation of RhoA","volume":"14","author":"Galle","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.060_bib0125","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00329.2005","article-title":"Hexosamines, insulin resistance and the complications of diabetes: current status","volume":"290","author":"Buse","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.060_bib0130","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.ATV.0000112012.33770.2a","article-title":"High glucose-induced upregulation of osteopontin is mediated via Rho\/Rho kinase pathway in cultured rat aortic smooth muscle cells","volume":"24","author":"Kawamura","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2018.07.060_bib0135","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.biopha.2017.03.056","article-title":"The role of SIRT1 in diabetic cardiomyopathy","volume":"90","author":"Karbasforooshan","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.07.060_bib0140","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.biopha.2017.10.075","article-title":"The role of SIRT1 in diabetic retinopathy","volume":"97","author":"Karbasforooshan","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.060_bib0145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1096\/fj.05-4197fje","article-title":"Rho-kinase as a molecular target for insulin resistance and hypertension","volume":"20","author":"Kanda","year":"2006","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.biopha.2018.07.060_bib0150","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.1074\/jbc.M110508200","article-title":"Active Rho kinase (ROK-alpha) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells","volume":"277","author":"Begum","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2018.07.060_bib0155","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1677\/JOE-06-0045","article-title":"A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats","volume":"192","author":"Kikuchi","year":"2007","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.biopha.2018.07.060_bib0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cca.2016.09.003","article-title":"Enhanced Rho-kinase activity: pathophysiological relevance in type 2 diabetes","volume":"462","author":"Liu","year":"2016","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.biopha.2018.07.060_bib0165","doi-asserted-by":"crossref","DOI":"10.1161\/01.HYP.0000125142.41703.64","article-title":"Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice","volume":"43","author":"Shiuchi","year":"2004","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.biopha.2018.07.060_bib0170","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1161\/01.RES.0000142313.68389.92","article-title":"Peroxisome proliferator-activated receptor \u03b3 ligands inhibit Rho\/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2","volume":"95","author":"Wakino","year":"2004","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.060_bib0175","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2337\/diabetes.51.2.443","article-title":"Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects","volume":"51","author":"Kim","year":"2002","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.biopha.2018.07.060_bib0180","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/HYPERTENSIONAHA.116.07518","article-title":"Internal pudental artery dysfunction in diabetes mellitus is mediated by NOX1-Derived ROS-, Nrf2-, and rho kinase-dependent mechanisms","volume":"68","author":"Alves-Lopes","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2018.07.060_bib0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1475-2840-11-65","article-title":"ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-1 expression and monocyte-endothelial cell adhesion","volume":"11","author":"Li","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"10.1016\/j.biopha.2018.07.060_bib0190","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1113\/expphysiol.1997.sp004038","article-title":"Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia","volume":"82","author":"Sobrevia","year":"1997","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.biopha.2018.07.060_bib0195","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.freeradbiomed.2014.05.016","article-title":"Regulation of obesity and insulin resistance by nitric oxide","volume":"73","author":"Sansbury","year":"2014","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.060_bib0200","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/diabetes.50.2.241","article-title":"Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle","volume":"50","author":"Higaki","year":"2001","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.biopha.2018.07.060_bib0205","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1590\/S0004-27302012000400001","article-title":"The role of the uncoupling protein 1 (UCP1) on the development of obesity and type 2 diabetes mellitus","volume":"56","author":"Brondani","year":"2012","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"issue":"157","key":"10.1016\/j.biopha.2018.07.060_bib0210","doi-asserted-by":"crossref","first-page":"ra3","DOI":"10.1126\/scisignal.2001227","article-title":"Rho and Rho-kinase activity in adipocytes contributes to a vicious cycle in obesity that may involve mechanical stretch","volume":"4","author":"Hara","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.biopha.2018.07.060_bib0215","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00249.2016","article-title":"OxLDL-induced endothelial proliferation via Rho\/ROCK\/Akt\/p27kip1 signaling: prevention by cholesterol loading","author":"Zhang","year":"2017","journal-title":"Am. J. Physiol., Cell Physiol."},{"issue":"27","key":"10.1016\/j.biopha.2018.07.060_bib0220","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.2174\/138161209789057986","article-title":"Rho kinase an important mediator of atherosclerosis and vascular disease","volume":"15","author":"Zhou","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"11","key":"10.1016\/j.biopha.2018.07.060_bib0225","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1248\/bpb.34.1684","article-title":"Rho kinase inhibition by fasudil has anti-inflammatory effects in hypercholesterolemic rats","volume":"34","author":"Ma","year":"2011","journal-title":"Biol. Pharm. Bull."},{"issue":"10","key":"10.1016\/j.biopha.2018.07.060_bib0230","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1440-1681.2011.05561.x","article-title":"Rho kinase inhibition by fasudil exerts antioxidant effects in hypercholesterolemic rats","volume":"38","author":"Ma","year":"2011","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2018.07.060_bib0235","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/01.RES.0000201960.04223.3c","article-title":"Rho kinases in cardiovascular physiology and pathophysiology","volume":"98","author":"Loirand","year":"2006","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.060_bib0240","doi-asserted-by":"crossref","first-page":"H287","DOI":"10.1152\/ajpheart.00327.2011","article-title":"Rho-kinase: important new therapeutic target in cardiovascular diseases","volume":"301","author":"Satoh","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2018.07.060_bib0245","doi-asserted-by":"crossref","DOI":"10.1186\/1476-511X-13-115","article-title":"Metformin enhances nitric oxide production and diminishes Rho kinase activity in rats with hyperlipidemia","volume":"13","author":"Liu","year":"2014","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.060_bib0250","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2017-000438","article-title":"Statin use and risk of developing diabetes: results from the Diabetes Prevention Program","volume":"5","author":"Crandall","year":"2017","journal-title":"BMJ Open Diabetes Res. Care"},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2018.07.060_bib0255","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1475-2840-12-S1-S3","article-title":"Statin diabetogenicity: guidance for clinicians","volume":"12","author":"Ray","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.060_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2014.04.001","article-title":"The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice","volume":"15","author":"Sattar","year":"2014","journal-title":"Atheroscler. Suppl."},{"issue":"3","key":"10.1016\/j.biopha.2018.07.060_bib0265","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1620\/tjem.235.171","article-title":"Opposing roles of nitric oxide and rho-kinase in lipid metabolism in mice","volume":"235","author":"Noda","year":"2015","journal-title":"Tohoku J. Exp. Med."},{"issue":"22","key":"10.1016\/j.biopha.2018.07.060_bib0270","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1007\/s00018-010-0460-1","article-title":"RhoA\/Rho-kinase and vascular diseases: what is the link?","volume":"67","author":"Nunes","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.060_bib0275","doi-asserted-by":"crossref","first-page":"H584","DOI":"10.1152\/ajpheart.01212.2010","article-title":"Role of myosin light chain kinase in regulation of basal blood pressure and maintenance of salt-induced hypertension","volume":"301","author":"He","year":"2011","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2018.07.060_bib0280","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.niox.2014.09.002","article-title":"Rho-kinase as a therapeutic target in vascular diseases: striking nitric oxide signaling","volume":"43","author":"Kolluru","year":"2014","journal-title":"Nitric Oxide"},{"issue":"10","key":"10.1016\/j.biopha.2018.07.060_bib0285","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1161\/ATVBAHA.111.227892","article-title":"Rho-associated kinase activity, endothelial function, and cardiovascular risk factors","volume":"31","author":"Soga","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.060_bib0290","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/cvr\/cvs422","article-title":"Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension","volume":"97","author":"Nguyen","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.060_bib0295","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/FJC.0b013e3182a3718f","article-title":"Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil","volume":"62","author":"Shi","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.biopha.2018.07.060_bib0300","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8029728","article-title":"Basal and activated calcium sensitization mediated by RhoA\/Rho kinase pathway in rats with genetic and salt hypertension","volume":"2017","author":"Behuliak","year":"2017","journal-title":"Biomed Res. Int."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.060_bib0305","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.tips.2005.12.002","article-title":"Targeting Rho and Rho-kinase in the treatment of cardiovascular disease","volume":"27","author":"Budzyn","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.060_bib0310","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCRESAHA.115.306532","article-title":"RhoA\/ Rho-Kinase in the cardiovascular System","volume":"118","author":"Shimokawa","year":"2016","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.biopha.2018.07.060_bib0315","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1161\/hy1201.096541","article-title":"Possible involvement of Rho-Kinase in the pathogenesis of hypertension in humans","volume":"38","author":"Masumoto","year":"2001","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.biopha.2018.07.060_bib0320","doi-asserted-by":"crossref","first-page":"9356","DOI":"10.1038\/s41598-018-27321-4","article-title":"The level of ROCK1 and ROCK2 in patients with pulmonary hypertension in plateau area","volume":"8","author":"Liu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2018.07.060_bib0325","article-title":"Fasudil preserves lung endothelial function and reduces pulmonary vascular remodeling in a rat model of endstage pulmonary hypertension with left heart disease","author":"Zhuang","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2018.07.060_bib0330","doi-asserted-by":"crossref","first-page":"3148259","DOI":"10.1155\/2018\/3148259","article-title":"Effects of fasudil on patients with pulmonary hypertension associated with left ventricular heart failure with preserved ejection fraction: a prospective intervention study","volume":"2018","author":"Zhang","year":"2018","journal-title":"Can. Respir. J."},{"issue":"3","key":"10.1016\/j.biopha.2018.07.060_bib0335","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/hrt.2003.029470","article-title":"Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension","volume":"91","author":"Fukumoto","year":"2005","journal-title":"Heart"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221833525X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221833525X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T20:28:31Z","timestamp":1751747311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333221833525X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":67,"alternative-id":["S075333221833525X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.07.060","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rho kinase, a potential target in the treatment of metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.07.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}